Corporate News 09-Dec-22
USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at the company's Oncology Injectable Formulation Facility at Panelav during the period from 4 October 2022 to 14 October 2022. This was pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA. The Company had also started receiving ANDA approval manufactured at this facility.
Previous News
Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
( Results - Announcements 04-Aug-23 14:15 )
Volumes soar at Lemon Tree Hotels Ltd counter
( Hot Pursuit - 02-Jan-24 11:00 )
Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
( Corporate News - 04-Jul-24 16:11 )
Alembic Pharma rises after USFDA approval for antifungal drug
( Hot Pursuit - 08-Apr-21 11:56 )
Alembic Pharma receives final approval for anti fungal drug
( Hot Pursuit - 08-Mar-22 11:36 )
Alembic Pharmaceuticals spurts on USFDA nod for Dabigatran Etexilate capsules
( Hot Pursuit - 07-Apr-22 11:47 )
Alembic Pharma get US FDA nod for acne topical gel
( Hot Pursuit - 08-Aug-22 11:19 )
Alembic Pharmaceuticals receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
( Corporate News - 08-Aug-22 11:04 )
Alembic receives USFDA final approval for an Opthalmic solution
( Corporate News - 05-May-21 11:35 )
Alembic Pharmaceuticals receives USFDA tentative approval for Palbociclib Capsules
( Corporate News - 09-Nov-20 10:11 )
Alembic Pharmaceuticals to conduct board meeting
( Corporate News - 17-Jul-20 16:49 )
Other Stories
Tinna Trade raises Rs 49 cr to fund its growth plans
06-Jul-24 11:10
Integra Essentia announces merger with G G Engineering
06-Jul-24 11:05
Ugro Capital to raise Rs 75 cr via NCD issuance
06-Jul-24 10:58
Board of D.P. Abhushan approves preferential allotment of shares and warrants
06-Jul-24 10:50
Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
06-Jul-24 10:49
High Energy Batteries (India) to discuss results
06-Jul-24 10:29
Havells India schedules board meeting
06-Jul-24 10:29
Axis Bank announces board meeting date
06-Jul-24 10:29
Mastek to conduct board meeting
06-Jul-24 10:29
Oriental Hotels to conduct board meeting
06-Jul-24 10:29
Back
Top
